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Background Small, wearable monitors are widely used to assess physical activity (PA) in obesity 
treatment programs ranging from lifestyle interventions to post-bariatric surgical programs. 
Although wearable monitors can overcome the recall biases often associated with self-reports, 
the accuracy of these devices may be impacted by anthropometric measures, mode of PA, and 
wear location. Thus, it is important to examine the accuracy of objective PA monitors during 
commonly performed activities such as walking. 
Methods Fifteen individuals with class III obesity completed a self-paced 6-minute walk while 
wearing the StepWatch 3 (SW3), Omron, Digiwalker (DW), SenseWear Pro 2 Armband (SWA), 
and Fitbit objective PA monitors. Simultaneously, energy expenditure (EE) was measured using 
a portable indirect calorimeter. Height, weight, hip circumference, and waist circumference were 
also measured. Monitor values for step counts and Calories were compared to hand tally counts 
and indirect calorimetry (IC), respectively. 
Results Step-counting percent errors (PE) were not significantly different among the SW3 
(PE=0.56%), Omron (PE=5.53%), and Fitbit (PE=4.33%). The DW significantly undercounted 
steps by 28% (p=0.037). The SWA overestimated EE by 71.6% (p=0.003), while the Fitbit’s 10% 
overestimate did not differ significantly from IC (p=0.114). 
Conclusion Objective monitors are useful for step counting and estimating energy expenditure, 
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Increasing rates of obesity are being reported globally, with the sharpest rises in 
prevalence coming in the highest BMI categories [1]. These individuals, classified as having 
class III obesity, are also afflicted by a long list of chronic diseases associated with excessive 
adiposity [2-4]. Weight loss is capable of improving health [5], and bariatric surgery has 
previously been described as the most effective option for long-term weight loss in individuals 
with morbid obesity [6]. The outcomes of these surgical procedures are largely dependent on 
patient behavioral modifications [7], with those combining physical activity with dietary 
restrictions achieving the greatest weight loss [8]. Thus, participation in physical activity appears 
to be a necessity in improving both weight status and health in this population. 
 Persons with class III obesity, including those awaiting bariatric surgery, prefer walking 
over all other modes of physical activity [9, 10]. Objective monitors, such as pedometers and 
accelerometers, record step counts during walking. These devices offer clinicians a tool for 
assessing adherence to walking-based exercise prescriptions, while also allowing patients to self-
monitor their own daily activity. In addition to recording steps, some monitors are able to 
estimate both daily and physical activity energy expenditure. 
 Pedometers and accelerometers are excellent tools for collecting data both in and out of 
the clinical setting. However, their accuracy may be compromised when worn by persons with 
class III obesity. Large waist circumference and slow walking speed negatively impact device 
accuracy during step counting [11], while speed and body composition regulate the metabolic 
cost of walking [12]. The ability to accurately relate step counts to walking energy expenditure 
would certainly aid in the prescription and monitoring of physical activity components of weight 
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interventions. Therefore, determining the accuracy of step-counting devices in persons with class 
III obesity would benefit healthcare providers and patients alike. 
While a number of objective monitors are capable of recording steps, newer technologies 
are being integrated into the assessment of PA. Spring-levered and piezo-electric pedometers 
rely on vertical accelerations at the hip to record steps. Accuracy of these devices is affected by 
physical characteristics of the wearer and walking speed [11, 13, 14]. In contrast, the ankle-worn 
StepWatch 3 Activity Monitor measures both vertical and horizontal accelerations and can 
record steps in a wide range of epochs. Due to its remarkable accuracy, it is considered the 
criterion for estimating steps in the free-living environment [15]. The SenseWear Pro 2 armband 
is worn on the right tricep and uses a dual-axis accelerometer and galvanic skin response, heat 
flux, and ambient temperature sensors to quantify PA [16]. This device has been used in several 
evaluative studies focusing on PA behaviors of bariatric patients [17-19]. The Fitbit is a 
relatively new objective monitor that records activity using a three-dimensional motion sensor 
similar to that of the Nintendo Wii. To our knowledge, no study has been published on the 
accuracy of this device in the severely obese. 
 By validating different objective physical activity monitors in persons with class III 
obesity, future researchers will be able to choose which device is best-suited for studies 
involving this population. With walking being the most widely prescribed form of physical 
activity in this population [20], accurate assessments of this activity are needed to determine the 
dose-response relationship between walking and health outcomes. Converting these step counts 
into estimates of energy expenditure would allow clinicians to quantify caloric expenditure 
during walking-based interventions. Therefore, the purposes of this study are to: 1) determine the 
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accuracy of step counting devices when worn by individuals with class III obesity and 2) 
estimate the metabolic cost of persons with class III obesity while walking at self-selected speeds. 
RESEARCH QUESTION: How accurate are the step counts and Calorie costs recorded by 
objective physical activity monitors when worn by individuals with class III obesity? 
RESEARCH HYPOTHESIS: Accuracy will be compromised by class III obesity in all waist-
mounted devices. Persons with class III obesity will walk at slower speeds than are commonly 
reported for normal weight individuals, but the metabolic cost of walking will be increased due 





REVIEW OF THE LITERATURE 
INTRODUCTION 
The prevalence of class III obesity in U.S. adults has risen from 0.9% between 1960 and 
1962 to 6.2% between 2005 and 2006 [21]. This has led to an exponential increase in bariatric 
surgeries being performed [22]. Physical activity (PA) plays an important role in both 
maximizing post-surgical weight loss [8], while pre-operational PA is related to increased 
volume and intensity of post-surgical PA [23]. The American College of Sports Medicine 
(ACSM) suggests walking is the most appropriate form of exercise for individuals with class III 
obesity [20]. Consideration must be given when prescribing walking-based PA to this population, 
as the metabolic cost of walking increases with increasing body fatness [24]. Therefore, there is a 
specific need for accurate assessments of both the volume and metabolic cost of walking in 
individuals with class III obesity. 
CLASS III OBESITY 
The World Health Organization (WHO) [25] and the National Heart Lung and Blood 
Institute (NHLBI)  [5] define obesity as having a body mass index (BMI) of at least 30 kg·m-2. 
This condition is accompanied by severe health implications, evinced by the WHO’s recent 
declaration of obesity being one of the top five risk conditions in developed nations [26]. 
Variations in health risks can be attributed to the extent of an individual’s obesity [27-29], 
warranting further classification. The NHLBI and WHO established three classes of obesity 
based on BMI ranges. Class I and II obesity are defined as a BMI range of 30-34.99 kg·m-2 and 
35-39.99 kg·m-2, respectively. An individual suffering from Class III obesity, interchangeably 
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referred to as extreme [5], severe, and morbid obesity [30], is diagnosed as having a BMI of at 
least 40 kg·m-2, or being 100 lbs. overweight for men or 80 lbs. overweight for women. Although 
the NHLBI and WHO classification charts end with class III obesity, the surgical literature often 
includes class IV and V obesity. Class IV, or super obesity, encompasses a BMI range of 50-59.9 
kg·m-2. Individuals with a BMI of 60 kg·m-2 or greater are said to suffer from Class V, or super-
super obesity [31].  
PREVALENCE 
While the prevalence of the obesity epidemic continues to increase globally [1], the 
steepest rises are reported in the highest BMI categories. Within the past twenty years, the 
worldwide prevalence of class III obesity has doubled [32]. Between 2000 and 2005, the number 
of persons in the US with a BMI ≥40 kg·m-2 increased by 52% [33]. Perhaps more alarmingly, 
there was a 75% rise in reported BMI’s ≥50 kg·m-2 during this same time period. As the heaviest 
individuals seem to only continue to gain weight, the 95th percentile of BMI’s has shifted to the 
right by 3.2 kg·m-2 [34].  Over 5% of all Americans are now believed to suffer from class III 
obesity [33]. This would suggest that of approximately 300 million Americans, nearly 15 million 
are severely obese.  
While, class III obesity appears to show no homogeneity in regards to age, race, or sex 
[35], certain groups may be more susceptible than others. The number of severely obese females 
doubles that of males [34], with the highest prevalence being reported for black women (15%) 
[32]. In terms of age, young adults are most affected by the rising rates of class III obesity. From 
age 18 to 35, the average weight gain is 30 pounds, and those who are already overweight 
experience the largest gains [36]. While these statistics are certainly cause for concern, the fact 
that they may fall short of actual values is most disturbing. Stommel and Schoenborn [37] found 
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that only 72% of individuals with class III obesity actually reported having a BMI ≥40 kg·m-2. 
Measured BMI was, on average, 2.12 kg·m-2 higher when compared to self-reported values. If 
this underreporting was applied to the population, an additional 1.9% of Americans might suffer 
from class III obesity [37].  
COMORBIDITIES 
While extreme adiposity may be the visual marker of class III obesity, underlying health 
conditions, or comorbidities, may have the greatest impact on healthcare. The McGraw-Hill 
Concise Dictionary of Modern Medicine [38] defines comorbidity as “the simultaneous presence 
of 2+ morbid conditions or diseases in the same patient, which may complicate a patient's 
hospital stay”. The long list of comorbidities commonly associated with class III obesity includes: 
hypertension (HTN), type 2 diabetes mellitus (DM2), gastroesophageal reflux, depression, 
nonalcoholic fatty liver disease, obstructive sleep apnea (OSA), osteoarthritis, urinary stress 
incontinence,  and breast, ovarian, gallbladder, and prostate cancers [2-4]. The most commonly 
reported comorbidity is HTN, with 52.3% of severely obese individuals having been diagnosed 
[27]. Bonfa et al. [39] report over 30% of class III obese persons suffer from depression, having 
a mental well-being comparable to cancer survivors and tetraplegics [40]. These high Beck 
Depression Inventory scores also coincided with poor perceptions of health-related quality of life 
but were unrelated to anthropometric measures, presence of diabetes, hypertension, osteoarthritis, 
or socioeconomic status [4]. Compared to normal weight individuals, severely obese persons are 
5.1 times more likely to develop DM2 and 2.2 times more likely to be diagnosed with 
dyslipidemia [27]. Not surprisingly, 20.7% of all adults diagnosed with DM2 are also severely 
obese [41]. Excessive adiposity results in high intra-abdominal pressure and causes chronic 
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hypoventilation [42], which could explain the high occurrence of pulmonary insufficiency in the 
severely obese [28]. 
In addition to these individual comorbidities, many severely obese individuals are also 
plagued by the metabolic syndrome. While it should be noted various medical societies have 
slightly different definitions , the American Heart Association (AHA) and NHLBI define the 
metabolic syndrome as a disease state in which an individual has three or more of the following 
risk factors for heart disease: waist circumference ≥ 40 inches for males or ≥ 35 inches for 
females, blood pressure > 130/85 mmHg, fasting triglyceride (TG) level > 150 mg/dl, fasting 
high-density lipoprotein (HDL) cholesterol level < 40 mg/dl for men or < 50 mg/dl for women, 
and fasting blood sugar > 100 mg/dl [43]. With increasing BMI comes a greater risk of being 
diagnosed with two or more of these comorbidities [29], supporting a prior report that up to 65.5% 
of severely obese individuals live with the metabolic syndrome [44]. In addition to the individual 
complications resulting from each risk factor, the condition as a whole is also associated with 
compromised health. For instance, presence of the metabolic syndrome is associated with a 
three-fold risk of cardiovascular morbidity [2]. 
HEALTHCARE COSTS 
With this long list of associated diseases, it should be no surprise that severely obese 
individuals face a substantial financial burden. In 2002, normal weight individuals spent an 
average of $4,000 per annum on health care; severely obese individuals spent double this amount 
[45]. It is worthy to mention the vast majority of these costs are due to underlying diseases 
associated with obesity. Of the total health care costs related to obesity, 85% can be attributed to 
HTN, dyslipidemia, coronary heart disease, DM2, and stroke [46]. The gaps in healthcare 
expenditures are also noticeable between obesity classes. There was a $2,717 spending 
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difference between women with class II and class III obesity, while the largest rise in costs for 
men was between classes I and II [45]. Rising healthcare spending is also associated with higher 
BMI in European countries. In the United Kingdom, there were significant differences between 
medication expenditures associated with class III obesity in comparison to both classes I and II 
[47]. To put these numbers into perspective, obese individuals (classes I,II, and III) spend 77% 
more on medications than persons of normal weight; there is only a 28% difference in 
medication costs between smokers and nonsmokers [48]. In addition to the exponentially higher 
costs of health care, productivity as an employee may also be affected by weight status. 
Individuals with class III obesity use twice as many sick days as the general population, while 
also drawing twice as frequent disability pension [49]. These statistics divulge the economic 
impact of class III obesity. 
WEIGHT LOSS 
The increasing prevalence of class III obesity cannot be blamed solely on a lack of desire 
to lose weight or prevent weight gain. In fact, the exact opposite may be true. A previous study 
reported up to 40% of women and 24% of men may be attempting to lose weight at any given 
time [50]. While the health benefits of weight loss are clear [46, 49, 51-53], often times weight 
loss efforts are ineffective in producing the necessary negative caloric balance. The reasons 
behind failed weight loss attempts are numerous. As health is only one determining factor in 
behavioral decision-making, this long-term outcome may be suppressed by more immediate 
factors. For instance, the cost of a healthy diet may exceed that of one comprised of energy-
dense, processed foods.  With an abundance of unhealthy and readily available fast food options 
and sedentary forms of electronic entertainment, today’s environment has become increasingly 
obesogenic. With the addition of time constraints due to demanding schedules, these 
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environmental influences become even more exaggerated. Constant interaction with these 
negative stimuli mandates successful weight loss programs address both dietary and PA 
components [51]. 
RECOMMENDATIONS 
According to the NHLBI [5], weight loss is indicated in all adults with a BMI ≥25 kg·m-2, 
males with a waist circumference (WC) ≥ 102 cm, and females with a WC ≥ 88 cm. This same 
report suggests reducing energy intake by 500-1,000 kcal·d-1, eliciting a minimum weight loss of 
1 to 2 pounds per week. The American College of Sports Medicine (ACSM) advises striving for 
a 5% to 10% reduction in body weight over 3 to 6 months, while reducing dietary fat to <30% of 
total energy intake [20]. A more radical approach is through a very low calorie diet (VLCD), 
where daily energy intake is reduced to 800 kcal. Supplementing existing information on dietary 
modifications, the US Department of Health and Human Services (USDHHS) issued the 2008 
Physical Activity Guidelines for Americans, where individuals seeking weight loss are 
encouraged to engage in 300 minutes of moderate-to-vigorous physical activity (MVPA) weekly 
[54]. The ACSM proposed similar guidelines, recommending 60 to 90 minutes of MVPA daily 
for weight loss and/or maintenance [20]. The USDHHS’s Dietary Guidelines for Americans, 
2010 reiterates the importance of PA participation in achieving caloric balance and maintaining 
weight [55]. 
CURRENT DIET 
When considering the elevated energy intake of class III obese persons, reductions in 
caloric intake must be a primary focus in producing a negative energy balance. In a study of 34 
severely obese individuals, average reported caloric intake totaled 3,442 ± 814 kcal·d-1; the 
average recommended caloric intake for their body size was 2,357 ± 511 kcal·d-1 [56]. This 
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difference results in a positive energy balance of over 1,000 kilocalories each day. These figures 
become even more alarming when considering bariatric patients are likely to underreport energy 
intake [57]. A similar study reported that class III obesity was associated with consuming 464 
kcal·d-1 than normal weight individuals [58]. This difference approximates the 500 kcal·d-1 
reduction recommended for weight loss. 
WEIGHT LOSS MAINTENANCE 
Obesity is now considered a chronic disease that requires long-term support for proper 
management [59]. While previous studies have shown diet and exercise to produce modest 
weight loss initially [60-62], long-term maintenance of this weight loss appears to present the 
biggest challenge. Wing and Hill [63] defined successful weight loss maintenance as 
“intentionally losing at least 10% of initial body weight and keeping it off for at least 1 year.” 
This 10% criterion is derived from numerous prior reports clearly documenting health benefits as 
a direct result of this percentage of weight loss [5]. Although this 10% reduction in body weight 
is unlikely to return an obese person to normal weight, it may still provide significant 
improvements in health. The famed Diabetes Prevention Program [64] proved even a 7% 
reduction in initial body weight through lifestyle changes can produce significantly greater 
reductions in risk of developing DM2 than pharmaceutical treatment. A similar study on Finnish 
subjects achieving an average 2-year weight loss of 3.5 kg reduced subjects’ risk of developing 
DM2 by 58% [53]. Oster et al. [46] report a 10% reduction in body weight may avert three years 
of HTN and approximately two years of DM2. This same 10% reduction in body weight was 
also predicted to decrease medical care costs by over $5,000. Urinary incontinence in women 
may also improve with modest 5-10% reductions in body weight [36]. At ten years of follow-up, 
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this weight loss corresponds to significant improvements in health-related quality of life (HRQL) 
scores in the severely obese [65]. 
REASONS FOR WEIGHT REGAIN 
Maintenance of this weight loss appears to pose the greatest challenge. Most individuals 
will regain 1/3 to 2/3 of the weight lost within the first year of starting a program [50]. Maclean 
et al. [66] report those unable to maintain weight loss had returned to their initial body weight by 
five years follow-up. Furthermore, these investigators found the rate of weight regain appeared 
to be at its highest immediately after cessation of the weight loss program [66]. One proposed 
explanation for this increase in body weight following weight reduction is a metabolic drive for 
excessive energy intake [66, 67]. In the weight-reduced state, carbohydrates (CHO) become the 
primary fuel, and fat oxidation appears to be suppressed [67]. This not only allows for greater 
deposition of fat into adipose tissue but may also trigger hunger signaling with depletion of CHO 
stores. Recommendations suggest keeping dietary fat below 30% of total caloric intake [20], 
potentially discouraging accumulation of adipose stores. It appears the best prevention of weight 
regain is life-long dedication to sustaining both reductions in caloric intake and improvements in 
PA participation. 
EFFECTIVE STRATEGIES 
Determining which approaches are most effective for continued weight control is of 
utmost importance in combatting weight regain. Established in 1994, the National Weight 
Control Registry (NWCR) is a database of individuals who have successfully preserved an 
average weight loss of 33 kg (72.6 lbs) for 5.7 years [68]. These individuals report utilizing a 
variety of strategies to fend off weight regain. The most commonly reported of these strategies 
are consumption of a low-calorie, low-fat diet, physical activity, and frequent self-weighing [69]. 
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These individuals report a caloric intake just over 1,300 kcal/day and exercise energy 
expenditures sometimes exceeding 3,200 kcal/day [68].  
Behavioral modifications have been shown to also produce encouraging results in 
persons with class III obesity. Unick et al. [52] report severely obese individuals in the Look 
AHEAD trial lost a greater percent of initial body weight than did overweight, class I, and class 
II obese individuals. Similarly, a 12-week intervention focusing on behavioral modifications 
produced an average 25% reduction in initial body weight in 1,100 severely obese patients [70]. 
Furthermore, these patients upheld 59% of this weight loss at the 72-week follow-up. Those who 
effectively maintain weight loss for two years reduce their odds of weight regain by nearly 50% 
[69]. However, meta-analysis of 29 behavioral interventions revealed just over a 3% reduction of 
initial body weight for all participants at 5-year follow-up [71]. 
To curb potential relapses, long-term contact with patients may be crucial in successful 
maintenance of weight loss. Perri et al. [72] found that patients who remained in contact with 
clinicians maintained significantly greater weight loss. Sustained contact may not be as 
challenging as it would seem, so long as continued clinical supervision is offered. When given 
the option, 87% of severely obese patients who had lost ≥ 100 lbs. during a weight loss 
intervention subsequently enrolled in an optional maintenance program [70]. This additional 




Whereas behavioral modifications often elicit meager long-term weight loss outcomes, 
bariatric surgery has grown in popularity and is now considered the most effective long-term 
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weight loss treatment [6]. Bariatric surgery entails a procedure or procedures that induce weight 
loss through limiting energy intake (restriction), reducing energy absorption (malabsorption), or 
both. In 1991, the National Institutes of Health (NIH) established the first guidelines for bariatric 
surgery, reserving its use for patients with a BMI ≥ 40 kg·m-2 or ≥35 kg·m-2 with high-risk 
comorbid conditions [73]. At the time these guidelines were published, less than 5,000 bariatric 
surgeries were performed annually; by 2009, this number increased to 220,000 [22]. The most 
commonly performed procedure is Roux-en-Y gastric bypass (RYGB) [2, 74]. RYGB combines 
restriction and malabsorption, reducing the stomach pouch to approximately 20 ml and 
bypassing the duodenum and a variable portion of the proximal jejunum [2]. Other common 
procedures include laparoscopic adjustable gastric banding (LAGB) and laproscopic sleeve 
gastrectomy (LSG). The latter is typically reserved for patients presenting with a BMI ≥ 60  
kg·m-2 or at a high risk for peri-operative morbidity and mortality [75]. The costs of these 
procedures and related medical care ranges from $20,000 to $50,000 [76]. In 2002, $948 million 
in healthcare spending was attributable to bariatric surgery [77]. 
PATIENT CHARACTERISTICS 
Patient populations in studies involving bariatric surgery are characteristically similar to 
one another. Between 70% and 90% of persons presenting for weight loss surgery are women [7, 
17, 78-81], and only about 10% of patients are nonwhite [7, 82, 83]. The onset of obesity 
normally occurs during early childhood [7], indicating the majority of these patients live with 
obesity for much of their lives. In addition, Bonfa et al. [39] report 27% of patients considering 
weight loss surgery had a family history of obesity. Over half of patients awaiting bariatric 
surgery suffer from two comorbidities, while 25% have been diagnosed with 3 or more [82]. The 
most commonly reported comorbidities are HTN (55.1%), OSA (48.9%), osteoarthritis (44.7%), 
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and DM (33.2%) [7, 17]. These individuals suffer not only from physical and metabolic 
conditions, but also psychological disorders. Binge eating disorder [84] and depression [7] are 
two of the most prevalent psychological disorders clinicians must address during patient 
evaluations. 
OUTCOMES 
Although bariatric surgery produces significantly better long-term outcomes than 
conventional strategies [49, 85, 86], wide inter-individual and inter-procedural variation has been 
reported. In an effort to adjust for inter-individual differences in absolute body weight, weight 
loss outcomes are typically reported as the percentage of excess body weight lost (%EWL). 
Previous studies report greater weight loss outcomes from RYGB than LAGB [74, 79, 86-88]. 
These studies show RYGB results in ≥60% EWL, compared to <50% for LAGB. However, 
the %EWL 2- to 3-years post-operation has been shown to range from 24.9% to 92.1% [17]. 
Longer follow-up periods have exposed that even surgery cannot fully prevent weight regain. 
Between 3- and 5-years post-operation, approximately 20% of RYGB patients did not achieve 50% 
EWL [89]. Karlsson et al. [65] report patients who had undergone bariatric surgery had regained 
1/3 of their initial weight loss by 6-year follow-up. In a study comparing the outcomes of short- 
and long-limb gastric bypass procedures, significant weight gain occurred in both surgical 
groups between 5- and 10-years follow-up [90]. In contrast, other studies have reported the 
ability of patients to sustain >50% EWL for over 15 years after the procedure [79, 88]. It is also 
worth mentioning that, out of 300 consecutive RYGB procedures, no patient gained weight 
postoperatively [7]. 
What factors affect post-surgical weight loss outcomes? Both pre- and post-operative 
patient characteristics and behaviors certainly play a crucial role. Most insurance companies 
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require enrollment in a 6- to 12-month clinically supervised weight loss program prior to 
operation. This stipulation is to gauge patient adherence to medical staff instruction; pre-surgical 
weight loss is generally not mandatory [22]. Therefore, these programs may fail to evaluate the 
individual’s motivation to attempt pre-operational weight loss through prescribed lifestyle 
modifications. Higher initial BMI has been associated with a slower rate of weight loss and 
poorer %EWL. Individuals presenting with BMI’s ≥ 50 achieved a significantly lesser % EWL 
than those with BMI’s between 40 and 50 kg·m-2 and regained 9% more of their pre-operative 
body weight at 6-year follow-up [91]. Approximately 70% of patients with a BMI >50 failed to 
achieve a BMI <35 at least 10 years after having undergone biliopancreatic diversion [92]. 
Despite these findings on the detrimental effect of a high pre-operational BMI on weight loss 
outcomes, the American Society for Metabolic and Bariatric Surgery (ASMBS) has recently 
published a position statement claiming a lack of evidence supporting the need for pre-surgical 
weight loss programs [93].  In a study determining predictors of post-surgical outcomes, initial 
BMI, level of education, presence of DM, PA participation, and post-operative appointment 
attendance explained 41% of the variability in weight loss following RYGB [7]. In this same 
study, patients with limited participation in PA achieved 17.2% less EWL than more active peers, 
whereas presence of DM2 hindered EWL by 6.2%. Following the post-surgical plateau in weight 
loss, Silver et al [94] identified current age, weight at age 21, initial BMI, and level of 
participation in PA as significant predictors of current BMI. In addition to patient behaviors and 
descriptors, surgeon experience has also been linked to post-operative weight loss outcomes [95]. 
While many factors appear to influence degree of weight loss achieved, the favorable effect of 





PA has been implicated as a vital component for successful weight loss and weight loss 
maintenance. It is also the only component of total energy expenditure that is modifiable from 
day to day [96]. The average caloric intake for 90% of 20- to 40-year-olds results in a positive 
energy balance of no more than 50 kcals·d-1, but this small imbalance leads to an average weight 
gain of 1.8 to 2.0 lbs per year [97]. Minimal increases in daily PA could easily curb this trend 
toward weight gain. Participation in PA reduces the extent of dietary restrictions necessary to 
achieve a negative energy balance. 
RECOMMENDATIONS 
The USDHHS issued PA recommendations in the 2008 Physical Activity Guidelines for 
Americans [54]. The recommendations state that all should adults engage in 150 minutes of 
moderate-to-vigorous physical activity (MVPA) or 75 minutes of vigorous physical activity 
(VPA) each week, accumulated in bouts of at least 10 minutes. MVPA and VPA are expressed as 
multiples of resting energy expenditure (REE), or 1 metabolic equivalent (MET). MVPA is 
defined as any activity of 3.0-5.9 METs, and VPA entails all activities ≥ 6 METs. In other words, 
a 3.0-MET activity corresponds to a 3-fold increase in REE. At least 300 minutes of MVPA (150 
min VPA) each week are recommended to induce weight loss [54]. In addition to this aerobic 
activity, resistance training at least twice each week is also recommended. A recent report has 
shown up to 50% of Americans fail to meet the recommendations for aerobic activity, and only 
18.2% engage in the recommended volumes of both aerobic and resistance exercise [98].  
COMPLIANCE 
While a large percentage of the general population meets the national PA guidelines, 
severely obese individuals are much less active. Only 4.3% of class III obese adults reported 
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engaging in moderate PA, compared to 18.1% and 35.5% of class I obese and normal weight 
individuals, respectively [27]. Using a multisensory armband to assess PA, Vanhecke et al. [99] 
showed severely obese persons spent 23 hours and 51.6 minutes per day in activities of <3 METs. 
The remaining 8.4 minutes were spent in moderate activity, with no individual spending any 
amount of time in VPA. The highest amount of activity recorded for any individual was 28 
minutes per day, still falling short of the established recommendations. 
Rates of physical inactivity appear to elevate in the highest BMI categories. Persons with 
a BMI ≥50 spend nearly an extra hour each day in sedentary behaviors than those with BMI’s 
ranging from 35 to 49.9 [19].  Both leisure-time and occupational levels of PA are significantly 
lower in women with class III obesity than  normal weight women, while daily television 
viewing is significantly higher [42]. Only 4.5% of patients awaiting bariatric surgery meet the 
150 min·wk-1 of MVPA recommendation, while over 68% engage in no bouts of at least 10 
minutes [80]. Additionally, only 14% of patients presenting for surgery have been in a PA 
program for at least 6 months [100]. This statistic alone conveys the lack of importance placed 
on PA in the required pre-operational weight loss programs. These percentages do appear to 
improve following surgery. Evans et al. [8] found 57.4% of patients self-reported engaging in 
≥150 min·wk-1 of MVPA one year after gastric bypass. However, after adjusting for the 10-
minute bout criterion patients’ post-operative time in MVPA fell from an average of 212.8 
min·wk-1 to 49.3 min·wk-1 [17]. While PA does appear to increase following surgery, post-
operative noncompliance rates are higher for PA than all other prescribed behavioral changes 




Before blaming the rising rates of class III obesity on failure to meet existing PA 
guidelines, special consideration must first be given to how intensity of exercise is determined. 
As previously mentioned, the 2008 Physical Activity Guidelines for Americans [54] classify 
intensity of exercise using multiples of 1 MET, or an oxygen consumption of 3.5 ml·kg-1·min-1. 
This value was derived from a 70 kg, 40-year-old man [102], and the general population may 
have values significantly lower than the referent [103]. Use of this 1-MET value to quantify 
intensity of PA leads to misclassification of many activities, and the rate of misclassification may 
be highest in sedentary, obese individuals [104]. 
Adipose tissue is only about 25% as active as fat free mass [105], so excessive adiposity 
in the severely obese reduces resting metabolic rate (RMR) [106, 107]. The effect of adiposity on 
RMR can be partly attributable to a lower proportion of slow-twitch muscle fibers [108]. This 
smaller portion of oxidative muscle fibers helps explain the 45% lower mitochondrial respiratory 
capacity and decreased mitochondrial uncoupling in severely obese compared to normal weight 
individuals [109]. Where normal weight individuals release energy as heat, the impaired 
mitochondrial uncoupling accompanying class III obesity results in greater energy storage. Each 
of these factors contributes to the lower RMR associated with class III obesity.  
As the level of obesity increases, the 1-MET value assigned to RMR becomes less 
applicable. Sleeping has previously been assigned a value of 0.9 METs [110]; the RMR of 
severely obese individuals may be lower than this [103].  A 3.0-MET activity (10.5 ml·kg-1·min-1) 
would, in turn, be more intense for a severely obese person with a low RMR than by a lean 
individual with a higher RMR.  
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PA & WEIGHT LOSS 
Of persons seeking to lose weight or working to maintain weight loss, those utilizing both 
diet and exercise are most successful [111]. Following a VLCD, obese persons engaging in high 
levels of PA reduced weight by 17.5 kg, whereas the moderate exercisers lost 9.3 kg at 2- to 3-
year follow-up [61]. Exercise has been proposed to enhance adherence to dietary restrictions 
[112], in turn, resulting in greater weight loss. The hypothalamic response to caloric restriction 
may be blunted through habitual PA, attenuating the desire to overfeed [66, 113]. Another study 
corroborates this theory by noting that no compensatory increase in caloric intake occurred 
following exercise [114]. Weight loss through caloric restriction alone may be detrimental to fat 
oxidation, as it has been found to decrease mitochondrial size [115]. PA was capable of 
increasing oxidative enzyme activity and mitochondrial volume, potentially overriding this 
disadvantageous effect of diet.  
Fat-free mass (FFM) is the central determinant in RMR [116] and explains 69% of the 
variance in RMR of formerly obese individuals following weight loss [117]. Individuals 
engaging in PA following weight loss surgery gained 8% more FFM than did non-exercising 
peers [118]. The ability of PA to attenuate loss of FFM clearly demonstrates its impact on total 
energy expenditure.  
In comparison to dietary therapy alone, the addition of PA increases weight loss 
outcomes through greater caloric expenditure. Severely obese adults who participated in a 12-
month diet and exercise weight loss intervention lost significantly more weight than those 
following the same program but beginning PA at 6 months [119]. Exercise prescriptions of 
varying intensity and duration (vigorous intensity/high duration, moderate intensity/high duration, 
moderate intensity/moderate duration, and vigorous intensity/moderate duration) leading to 
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weekly energy expenditures of 1,000 kcal and 2,000 kcal, combined with caloric restriction, 
produced no significant differences in weight loss between groups of obese, formerly sedentary 
women [120]. These results suggest the role of caloric expenditure resulting from PA, in terms of 
weight loss, supersedes that of intensity and duration. Persons with class III obesity may have 
difficulties engaging in high-intensity PA, so these results are particularly important for this 
population.  
PA plays an important role in the maintenance of weight loss as well. Nearly 90% of 
NWCR participants reported combining diet and PA, while only 10% used diet alone [68]. In 
comparison to those who regained weight, successful maintainers expended approximately 2,000 
kcal·wk-1 more in PA [121]. Subsequent weight regain also varies when comparing diet and PA. 
Unlike weight regain following dietary-induced weight loss, weight regain after PA-induced 
weight loss is independent of the preceding weight reduction [122]. PA plays a critical role in 
both maximizing initial weight loss and maintaining that weight loss over time. 
PA & BARIATRIC SURGERY 
PA has also been shown to enhance the effects of weight loss surgery [7, 8, 17, 74, 123], 
while physical inactivity has been described as one of the two most detrimental factors to post-
surgical weight loss outcomes [124]. Participation in pre-operational PA may also correlate with 
post-surgical weight loss. Those patients incapable of walking two city blocks lost 17.2% less 
excess body weight at 1-year follow-up [7].  In addition, becoming physically active before 
surgery may increase post-operational levels of PA and the intensity of this activity [23]. 
Following gastric bypass, patients who engaged in 150 min·wk-1 of MVPA experienced 
significantly greater weight loss, reductions in BMI, %EWL, and total percentage of weight lost 
than those failing to meet PA recommendations [8]. As much as 35% of weight lost at 1-year 
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post-operation is FFM, and this loss of FFM is directly correlated to the decrease in absolute 
RMR [125]. Individuals who reported engaging in post-operative PA significantly increased both 
FFM and percentage of fat mass lost in comparison to non-exercisers [118]. In a similar study, 
PA actually increased muscular strength following gastric bypass [126]. Non-exercising controls 
lost significant amounts of strength in their quadriceps (-16%), biceps (-36%), and triceps (-39%). 
Therefore, it appears PA increases surgically-induced weight loss through both increasing energy 
expenditure and retaining or increasing FFM. Though PA improves weight loss outcomes, there 
are currently no available guidelines on exercise following bariatric surgery. 
BENEFITS BEYOND WEIGHT LOSS 
Participation in PA has implications outside of increasing weight loss outcomes. 
Physically active obese individuals have lower risks of mortality and morbidity than physically 
inactive lean individuals, and physical inactivity is as strong a predictor of mortality as is obesity 
[127]. Obese adults who engaged in at least 2 hours of weekly PA reduced their risk of 
developing the metabolic syndrome by 19% [44], while accumulating 150 minutes of MVPA per 
week reduced the risk of developing glucose intolerance, dyslipidemia, and hypertension by 86% 
[128]. Meeting the 2008 PA guidelines is also associated with a reduced prevalence of the 
metabolic syndrome [129]. Aerobic capacity is linked to cardiovascular disease [130] and is 
improved with PA participation [131, 132]. This is particularly important in the severely obese, 
as their fitness levels are not significantly different than those of individuals diagnosed with heart 
failure [133]. After adjusting for cardiorespiratory fitness, neither obesity nor presence of 
metabolic syndrome are significantly related to risk of all-cause mortality [134]. A 1-MET 
increase in aerobic capacity has been associated with up to a 35% reduction in all-cause 
mortality [135] and a 5.4% reduction in healthcare costs [130]. Cardiorespiratory fitness is also 
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inversely associated with surgical complications following gastric bypass [130]. Following 
bariatric surgery, cardiorespiratory fitness may decrease as a result of decreased FFM [125, 136] 
and reduced cardiovascular strain from the drastic weight reduction [137]. An exercise program 
would be necessary in both maintaining lean tissue and heart function, and has been shown to 
increase post-operative aerobic capacity by as much as 50% [138]. Bariatric surgery is probably 
incapable of improving cardiovascular function without accompanying exercise participation. In 
the absence of post-operative PA, weight loss surgery had no significant effect on resting heart 
rate (HR) or blood pressure [138]. Bariatric surgery does not typically impact high-density 
lipoprotein (HDL) cholesterol levels [79], but PA has been shown to improve HDL in obese 
individuals [139]. In comparison to non-exercisers, individuals participating in post-surgical PA 
improve health outcomes beyond weight loss alone. 
WALKING FOR PHYSICAL ACTIVITY 
The benefits of incorporating PA into any weight loss program are clear; the difficulty 
lies in developing approaches capable of arousing weight loss seekers to begin an exercise 
regimen. One of the most effective methods may be to encourage walking, particularly in 
persons with class III obesity [20]. The health benefits of walking are well documented [140-
142], and most individuals walk to perform common tasks each day. Walking does not require an 
often expensive health club membership, carries a low risk for injury, and can be performed 
alone or with a group [132], making it one of the most convenient modes of PA. In addition to 
walking, the ACSM lists cycle ergometry as an appropriate form of exercise in the severely 
obese population [20]. However, the heart rate response relative to the oxygen requirement of 
cycling far exceeds that of walking [106]. In practical terms, an individual with class III obesity 
would be forced to cycle for a longer duration at a higher heart rate to attain an equal caloric 
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expenditure to that of walking. Additionally, walking may alleviate some of the perceived 
barriers to PA reported by persons with class III obesity. While severely obese patients seeking 
weight loss treatment show a desire to become physically active [78, 138], concerns about 
wearing tight-fitting sports clothing and a lack of accommodating exercise equipment were 
common obstacles [143]. Walking appears to be a viable solution to alleviating these hindrances. 
PREVALENCE OF WALKING 
Walking seems to be the most appealing type of LTPA across BMI categories. A higher 
percentage of obese men (33.9%) walk for LTPA than overweight (30.0%) and normal weight 
(28.0%) peers, while the percentage of obese women (45.6%) reporting walking is comparable to 
those of overweight (49.1%) and normal weight (47.5%) groups [9]. Walking is also the most 
common type of PA reported by individuals seeking or maintaining weight loss. Of adults trying 
to lose weight, 37.7% of men and 52.5% of women incorporated walking into their weight loss 
strategies [144]. In a study evaluating exercise in patients awaiting bariatric surgery, 44% of 
reported PA came from walking [10]. Also an effective tool in maintaining weight loss, 76% of 
individuals enrolled in the NWCR reported walking for PA [68]. These data suggest walking 
may be the mode of exercise most prone to impact PA levels of the severely obese while also 
playing a critical role in weight loss maintenance. 
RECOMMENDATIONS 
Walking is believed to be the most successful tool for increasing PA, from a public health 
perspective [145]. This has led to an interest in establishing guidelines specific to walking. The 
10,000 steps-per-day goal is perhaps the most recognizable guideline in place today and has been 
employed in numerous walking-based PA interventions [140, 146, 147]. Tudor-Locke and 
Bassett [148] proposed indices based on daily step counts for classifying PA levels. Individuals 
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accumulating at least 10,000 steps each day were classified as active. This cut-off seems 
appropriate, as 73% of individuals meeting the 30 min·d-1 guidelines also walked 10,000  
steps·d-1 [149].  In turn, sedentarism was defined as taking fewer than 5,000 daily steps.  
Speed must also be considered when establishing walking recommendations. The 2008 
Physical Activity Guidelines for Americans [54] suggest walking at least 3 mph for MVPA, 
while Ainsworth et al. [110] define “walking for exercise” as a speed of 5.6 km·h-1 (3.48 mph). 
Stepping rate has also been used to quantify the intensity of walking. Taking 3,000 steps in thirty 
minutes has previously been proposed as a cut-point for MVPA [148, 150]. However, the current 
standardized intensities for walking do not consider individual differences in body size and may 
not be appropriate for use in exercise prescriptions across differing populations [110]. The 
applicability of these step goals to the severely obese population has yet to be determined. 
CONSIDERATIONS FOR CLASS III OBESITY 
Although walking is the most commonly reported form of PA in the severely obese, these 
individuals fall far short of reaching current recommendations. Using the cut-points proposed by 
Tudor-Locke and Bassett [148], 20% of patients awaiting bariatric surgery were sedentary, and 
81% failed to accumulate 10,000 steps per day [10]. In this same study, BMI was inversely 
related to both daily steps and steps per minute during the most active 30 minutes of the day. 
Vanhecke et al. [99] found severely obese subjects took an average of only 3,763 steps each day.  
Several factors explain the negative impact of class III obesity on daily step counts. A 10 
kg·m-2 increase in BMI was shown to coincide with over a 300% decrease in the likelihood of 
completing a 400 m walk [151]. Percent body fat is positively correlated with the amount of 
steps required to walk a given distance [149]. From this, those subjects with the highest levels of 
adiposity are not only taking an insufficient amount of steps each day but are also covering a 
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shorter distance. Low daily step counts may be largely attributable to physical limitations 
associated with class III obesity. Walking one city block or up one flight of stairs may often 
induce dyspnea in this population [28]. Skin friction, foot, knee, and low back pain, and hip 
arthritis were all reported significantly more often by severely obese women after walking than 
by normal weight peers [42]. In a study of 2,458 patients awaiting bariatric surgery, 16% used an 
assistive device for walking and 64% experienced difficulties walking several blocks [151]. 
Interestingly, 41% of those reporting these difficulties did not have an objectively measured 
mobility deficit. This may suggest physical discomfort is viewed as a barrier to walking, even 
without a physician’s diagnosis. Whether the limitations to walking are real or perceived, class 
III obesity is clearly associated with a decrease in daily steps. 
WALKING SPEED 
Speed is a determinant of walking intensity, and self-selected walking speed significantly 
decreases as BMI and body weight increase [152]. Walking is believed to be most efficient in 
terms of energy expenditure at speeds around 3 mph [153], and, in a study of adults aged 20-79, 
only women over age 60 and men over age 70 were found to select comfortable walking speeds 
below this standard [154]. This is a considerably faster pace than is commonly observed for 
those with class III obesity. When asked to walk at a comfortable speed, severely obese women 
awaiting weight loss surgery were found to walk at 1.7 mph [155]. The slowest comfortable 
speed reported was a mere 0.81 mph, approximately ¼ the value corresponding to moderate-
intensity PA [155]. 
Walking speed is also used in the clinical assessment of both functionality and fitness, 
commonly through use of the 6-minute walk test (6MWT). Previous studies have used the 
6MWT to assess functional capacity in patients awaiting bariatric surgery [42, 156, 157]. 
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Average pre-operative walking speeds ranged from 1.6 to 2.96 mph, with larger standard 
deviations as body weight increased [42]. The corresponding distances of these tests equals, on 
average, only 55% of the values attained by normal healthy adults [158]. A similar study by King 
et al. [151] found the average pre-operational walking speed to be 2.4 mph, but 24% of patients 
walked at speeds slower than 2.13 mph. Additionally, each 10 kg·m-2 increase in BMI increased 
time taken to walk 400 m by 10% [151]. Furthermore, patients with an average BMI of 69  
kg·m-2 were previously found to be incapable of completing a 6-minute treadmill walk at 2 mph 
without developing metabolic acidosis or exceeding a respiratory exchange ratio (RER) of 1.0 
[159]. Also worthy of mention considering its high prevalence in class III obesity, the preferred 
walking speed of 40- to 70-year-olds of varying weight statuses diagnosed with DM2 averaged 
only 2.05 mph [160].  
ADDITIONAL CONSIDERATIONS 
Class III obesity places considerably greater stress on the cardiovascular system. For 
instance, walking speeds between 2.8 to 3.3 mph require oxygen consumptions corresponding to 
as much as 75% of this population’s maximal aerobic capacity [106]. While this may limit the 
exercise capacity of severely obese individuals, walking at slow speeds may still provide 
significant health benefits. When “walking for pleasure,” obese individuals reached 70% of age-
predicted maximal HR, as opposed to 59% in the normal weight group [161]. Similarly, 
Mattsson et al. [162] found walking at a self-selected, comfortable speed corresponded to 56% 
and 36% of peak aerobic capacity in obese and lean women, respectively. The clinical 
implication of these findings is emphasized when considering the obese groups attained these 
higher values while walking at significantly slower speeds. This suggests that walking speed may 
not be indicative of the relative effort of the activity, particularly when performed by severely 
27 
 
obese individuals. Furthermore, even those individuals who walk at speeds below 2 mph have a 
44% lower risk of developing heart disease than non-walkers [141]. Gallagher et al. [133] 
proposed that walking speeds as slow as 1 mph may be enough to improve cardiorespiratory 
fitness in severely obese persons. It can be gathered that this population is sure to benefit from 
walking, regardless of whether or not the recognized standards for speed are being met. 
METABOLIC COST OF WALKING 
The metabolic cost of walking is dependent upon several factors and can differ greatly 
between lean and obese individuals. Level of fitness, biomechanical efficiency, body 
composition, walking speed, and environment are all determinants of the energy expenditure (EE) 
during walking [12]. Body fatness is negatively correlated to walking efficiency [24]; the more 
body fat an individual carries, the greater the energy requirement of walking. For example, a 
100-kg obese individual burns approximately twice as many calories as a normal weight person 
weighing 50-kg during a 1-mile walk [163]. Body weight has previously been shown to explain 
up to 92% of the variance in the metabolic cost of walking at a given speed [106], while 
Browning et al. [12] showed that body fat percentage accounts for 45% of these differences. 
The interpretation of these and other studies is clear; adiposity has a considerable effect 
on walking EE. Faster walking speeds may have a greater effect on those with a high degree of 
body fat as a result of increased inertia, decreasing efficiency and, in turn, increasing EE [107, 
164]. In a study comparing mass-specific gross EE during walking in lean and obese individuals 
[106], no significant differences were found at 2.2 mph. At 2.9 mph, EE was 13% higher in the 
obese group. While differences in EE may be negligible at slower speeds, the effect of obesity on 
relative intensity is more apparent. A speed of 1.55 mph corresponded to 58% and 34% of peak 
aerobic capacity in obese and lean individuals, respectively [165]. Differences in EE before and 
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after weight loss also highlight the effects of body weight on the energy requirement of walking. 
Following extreme weight loss, the metabolic cost of walking is reduced beyond what would be 
expected from weight loss alone [166]. Proposed explanations for this inconsistency are 
biomechanical alterations and reduced thigh skin friction. 
Net EE during walking has also been examined in lean and obese individuals. The net 
metabolic cost of walking is calculated by subtracting standing EE from EE during walking. 
Using net as opposed to gross values focuses solely on the metabolic cost of walking by 
eliminating inequalities in standing EE. After correcting for body mass, the metabolic cost of 
standing was 40% lower in obese than lean adults [167]. At 3 mph, gross and net EE were 27% 
and 31% higher in obese versus normal weight persons [96]. Net EE may be best-suited to 
determine the metabolic cost of the act of walking. However, gross EE is a more relevant 
measure when total caloric expenditure is of interest, such as in weight loss programs. 
OBJECTIVE PHYSICAL ACTIVITY MONITORS 
Many devices are now capable of objectively quantifying PA. Objective monitors have 
previously been used to establish thresholds for the classification of PA levels [148]. These 
devices have improved accuracy for assessing ambulatory activity and can be used to allow 
clinicians to assess adherence to exercise prescriptions.  
OBJECTIVE MONITORS VS. SELF-REPORTS 
Self-reported measures of PA are subject to recall bias, particularly when used in studies 
involving the clinically obese. Obese individuals claiming to be resistant to conventional weight 
loss treatment over-reported PA by 51 ± 75% [168]. According to Evans et al. [8] self-reported 
PA may poorly reflect actual participation following bariatric surgery, particularly in the first 3 
months. They propose that during this time frame, exercise may be incapable of counteracting 
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the metabolic changes occurring from such drastic reductions in energy intake. In other words, 
the dietary restrictions imposed following weight loss surgery may decrease the metabolic rate to 
an extent that cannot be fully compensated through PA. PA levels may be at their lowest in the 
weeks immediately following surgery, gradually increasing throughout follow-up. Therefore, PA 
at the time of the questionnaire may not represent that of the entire 3-month period. 
The correlations between objective devices and subjective questionnaires differ among 
studies [169-171]. However, even a high correlation coefficient may simply denote agreement in 
the ranking of subjects by PA levels, rather than quantitative agreement [170]. In a pre-surgical 
evaluation of PA behaviors in bariatric patients, only 2-5% of the variance in objectively 
measured PA was explained by self-reports [10]. Even the International Physical Activity 
Questionnaire (IPAQ), having been validated in 12 countries, was only moderately correlated 
with accelerometry (r = 0.33) [172]. Furthermore, use of the IPAQ in bariatric patients has been 
shown to under-emphasize the relationship between abdominal obesity and PA [173].  
With walking being the preferred type of PA for most individuals, accurate assessment of 
this behavior is a high priority. However, walking may be especially susceptible to the 
discrepancies between self-reports and objective measures. The Behavioral Risk Factor 
Surveillance System (BRFSS) fails to assess LTPA and walking separately, resulting in up to 5-
fold underestimates in self-reported walking distance [170].  It is evident that PA should be 
assessed via objective monitoring, at least in combination with self-reports, whenever possible. 
In addition to providing more accurate data than self-reports, objective monitors are also capable 




Objective PA monitors can also have a positive impact on outcomes of weight loss 
programs. It has been proposed that avoiding a change from group-based exercise programs to a 
post-intervention PA program relying solely on the individual improves the odds of behavioral 
maintenance [132]. Objective monitors allow the individual to record data on daily exercise, 
potentially creating a routine of self-monitoring. Poor PA participation following bariatric 
surgery has been attributed to a lack of immediate reinforcement [101]. The data displayed on 
the objective monitor can provide motivation to exercise after weight loss surgery. Many 
monitors are capable of storing several weeks’ worth of data, so medical staff may be able to 
reduce the frequency of post-operative appointments used to assess patient adherence to exercise 
prescriptions. 
PA monitors can effectively increase PA and adherence to PA prescriptions [174-176], 
thereby improving health benefits. In comparison to subjects without an objective monitor, those 
given a pedometer during a walking intervention had significantly greater improvements in 
glucose tolerance [177]. Adults ages 65 and older increased daily step counts by 27% during a 
pedometer-driven walking intervention; these gains were lost after removing the devices [178]. 
Moreover, a recent review found that studies that used a pedometer, daily step goal, and PA log 
increased activity by an average of 2,500 steps per day [174]. 
Some PA monitors are also capable of estimating daily and exercise EE. These devices 
become particularly useful when assessing lifestyle changes in bariatric patients. Following 
surgery, these individuals experience declines in both resting [179] and walking EE [155]. 
Accurate estimates of EE would be a valuable resource in maximizing post-surgical weight loss. 
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Quantification of PA potentially offers clinicians the opportunity to discern whether patients are 
complying with dietary and PA goals. 
SPRING-LEVERED PEDOMETERS 
Pedometers are devices capable of recording steps taken throughout the day. The simplest 
of these devices is the spring-levered pedometer. In order for a pedometer to accurately assess 
step counts, the device must be positioned vertically on the body. During walking, steps are 
recorded when vertical accelerations of the trunk cause the movement of a spring-suspended 
horizontal lever arm. Spring-levered pedometers are less accurate in counting steps of obese 
individuals in comparison to normal weight peers. Shepherd et al. [180]  found strong positive 
correlations between pedometer error and BMI (r = 0.792) and body weight (r = 0.753). The 
Yamax SW-200 (Yamax Inc., Tokyo, Japan) undercounted the steps of persons weighing over 
100 kg by 11-15% versus 3-7% in those under 100 kg [152]. Excessive adiposity at the waist 
may dampen these oscillations, and the force exerted on the lever arm may be insufficient to 
record the step [14]. Additionally, a large waist circumference (WC) may tilt the pedometer out 
of the vertical plane, decreasing movement of the lever arm required for step counting [13]. 
When held against the waist of an obese individual with an elastic undergarment, step-counting 
accuracy drastically improved [180].  
Walking speed is inversely related with pedometer accuracy [13]. When considering self-
selected walking speed decreases with increasing BMI [152], this effect is of particular 
importance in the evaluation of PA in the severely obese. At speeds of 80 m·min-1 and slower, 
WC and BMI were inversely related to pedometer accuracy [14].  While speed and 
anthropometrics negatively affected device accuracy at slower speeds, pedometer tilt angle had 
the greatest effect across all speeds. Pedometer tilt angle is influenced by adiposity at the waist, 
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and thus the accuracy of these devices in persons with class III obesity is decreased. As a result 
of differences in self-selected walking speed and tilt angle, the Digi-Walker SW-200 spring-
levered pedometer may undercount steps in obese persons by twice as much as in normal weight 
individuals [11].  However, not all studies have corroborated these findings. At 2.0 and 2.5 mph, 
accuracy of the Yamax SW-200 was significantly affected by speed but not BMI [13].  
PIEZO-ELECTRIC PEDOMETERS 
Similar to spring-levered pedometers, most piezo-electric pedometers are also worn on 
the belt or waistband. During ambulation, a piezo-electric accelerometer records the vertical 
accelerations of the body, and these data are used to generate estimates of energy expenditure. 
Steps are recorded by counting the number of peaks or zero-crossings of the acceleration with 
respect to the time recording [14]. These devices are better-suited for obese individuals who 
usually walk at slower speeds [152]. Accuracy of the New Lifestyles NL-2000 piezo-electric 
pedometer was unaffected by BMI, WC, and pedometer tilt angle [14]. It must be noted that 
individuals incapable of walking at 4 mph were excluded from this study, and the average 
walking speeds of severely obese individuals fall short of this pace [151, 156, 158]. While BMI 
and slow step-rate percentage affected the Digi-Walker accuracy in free-living activity, the 
accuracy of the New Lifestyles device was dependent only on stepping rate [11]. The Omron HJ-
720ITC (Omron Industries) records steps with an absolute error of less than 3% while walking at 
both predetermined and self-selected speeds[181]. The Omron is most accurate when worn in the 
pocket and recorded with 65% accuracy in obese persons over a 24-hour period [182]. Even 
when worn in the pocket, this device was more accurate than the waist-mounted Yamax. This 
may be another possible advantage as opposed to spring-levered devices, as a pocket pedometer 
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is less reliant on positioning within the vertical plane to record steps. However, the Omron has a 
4-second step filter, which leads to undercounting in the free-living environment [183]. 
STEPWATCH 
During walking, more movement occurs at the ankle than at the hip [11]. The StepWatch 
is worn at the ankle and uses a dual-axis accelerometer to count steps. This device has been 
reported as more accurate than both spring-levered and piezo-electric pedometers at various 
speeds, including perfect accuracy in a small sample of severely obese persons [180]. It has since 
been used as a criterion pedometer [11, 182]. Where thresholds of 0.30-0.35g are necessary to 
record a step in most waist-mounted pedometers, ankle-mounted devices may be more sensitive 
[11]. Because it uses accelerometry to record steps, this device is also capable of recording 
minute-by-minute stepping rates [180]. This data can be stored for 24-hour periods over multiple 
days [11] and is transmitted to a personal computer via an infrared relay [180]. The StepWatch is 
also superior to both spring-levered and piezo-electric pedometers during stair climbing [180]. 
The StepWatch was previously been used in prediction equations to estimate walking EE, and 
approximately 66% of the variance in the metabolic cost of walking could be explained from 
StepWatch step counts [184]. 
SENSEWEAR 
A newer device combines innovative technology, accelerometry, and proprietary 
prediction equations to analyze both total and daily PA. The SenseWearTM Armband 
(BodyMedia, Inc. Pittsburgh, PA) is worn on the upper right arm and is capable of counting steps, 
estimating EE, and determining intensity of PA over a 24-hour period for multiple days. Data are 
collected via a dual-axis accelerometer, galvanic skin response sensor, heat flux sensor, and an 
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ambient temperature sensor [185]. PA measurements from this device were similar to those of a 
triaxial accelerometer in a study involving persons awaiting bariatric surgery [16]. 
Even with the advanced technology of this device, energy expenditure assessments 
appear far from perfect. When compared to doubly labeled water (DLW), the SenseWear 
armband (SWA) significantly underestimated daily EE by 117 kcal in healthy adults (BMI 
18≤35) [18]. An intraclass correlation of 0.81 showed that, despite group differences, individual 
comparisons between SWA and DLW were similar. Its ability to discriminate between periods of 
rest and activity [149] has led to its use in the evaluation of sedentary behaviors in severely 
obese individuals [19]. In a study assessing SWA accuracy in obese individuals (BMI 42.3 ± 7.0), 
REE was underestimated by an average of 8.8% [186]. Conversely, SWA significantly 
overestimated EE during treadmill walking. Detecting changes in grade also appears to pose a 
problem when estimating EE. EE was significantly overestimated by 13-27% while walking 
without a grade, in contrast to 22% underestimations after adding a 5% grade [185]. These 
subjects were far leaner than persons with class III obesity, warranting similar studies in the class 
III obese population. Interventions may benefit from using this device to encourage patient self-
monitoring, lowering the cost of care for both subjects and clinicians. Additionally, overweight 
and obese individuals reduced blood glucose when receiving group intervention with SWA and 
when receiving SWA alone [187], indicating use of this device may be capable of improving 
health even in the absence of a structured exercise program. 
SUMMARY 
 Validating objective monitors in severely obese individuals is a crucial step in both 
determining volumes of PA necessary for maximizing weight loss and assessing adherence to 
exercise prescriptions. Determining which devices are most accurate when worn by these 
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individuals will improve quantitative measures of PA in future studies involving the severely 
obese. Additionally, estimating the metabolic cost of walking in this population will allow 
clinicians to approximate caloric expenditure during walking-based interventions. These results 
could lead to the establishment of pre- and post-operative PA recommendations for obese 







 The prevalence of obesity continues to increase globally [1]. The highest rate of increase 
has been in class III, also known as morbid or severe, obesity [32-34]. Over the past twenty years, 
the worldwide prevalence of class III obesity has doubled [32]. Behavioral interventions are 
capable of reducing body weight in the severely obese [52], and those combining diet and 
exercise produce greater long-term results [111]. Bariatric surgery is now considered the most 
effective weight loss treatment for severely obese individuals [6], and participation in physical 
activity (PA) improves post-surgical weight loss outcomes [188]. Clearly, PA plays an integral 
role in both behavioral and surgical weight loss interventions. 
Objective monitors record PA data in the free-living environment and have been shown 
to increase PA and adherence to PA prescriptions [174-176]. Objective monitoring is particularly 
valuable in individuals with class III obesity, as they tend to over-report PA participation [168]. 
Currently, only self-reported measures have been validated for assessing PA in the bariatric 
population [123]. However, only 2-5% of the variance in objectively measured pre-operative PA 
is explained by self-reports [10]. Walking comprises 44% of total PA prior to surgery coming 
from walking [10], and 76% of National Weight Control Registry participants report walking as 
a part of their strategy to maintain weight loss [68]. Thus, accurate assessment of this activity is 
necessary. 
Pedometers and accelerometers are both capable of recording data during ambulatory 
activities. The simplest of these devices is the spring-levered pedometer. Worn at the waist, 
pedometers record steps when vertical accelerations of the trunk trigger the movement of a 
37 
 
spring-suspended horizontal lever arm. However, the accuracy of spring-levered pedometers is 
reduced in obese individuals and with slow walking speeds [13, 152, 180]. Piezo-electric 
pedometers record vertical accelerations of the body during ambulation, and steps are recorded 
by counting the number of peaks or zero-crossings of the acceleration vs. time recording [14]. 
The accuracy of piezo-electric pedometers is not influenced by BMI [14], but is reduced at 
slower walking speeds [11].  
Another step-counting device, the StepWatch 3 (Orthocare Innovations, Oklahoma City, 
OK) is worn at the ankle and uses a dual-axis accelerometer to count steps. This device is more 
accurate than spring-levered and piezo-electric pedometers and had near-perfect accuracy in a 
small sample of severely obese persons [180]. It has since been used as a criterion pedometer [11, 
182].  
Newer devices rely on advanced technology to more accurately quantify the intensity of 
free-living PA. The SenseWear Armband (BodyMedia, Inc. Pittsburgh, PA) is worn on the upper 
right arm and collects data via a dual-axis accelerometer and galvanic skin response, heat flux, 
and ambient temperature sensors [185]. Measured PA intensities from this device were similar to 
those from a waist-worn triaxial accelerometer in a study involving persons awaiting bariatric 
surgery [16]. The Fitbit (Fitbit Inc., San Francisco, CA) is a wearable PA monitor that records 
three-dimensional accelerations using an accelerometer. Both use proprietary algorithms 
involving pattern recognition to convert acceleration to energy expenditure (EE), but, to our 
knowledge, no study has been published on the accuracy of this device in individuals with severe 
obesity. Therefore, the aim of the current study was to determine the accuracy of objective 





Participants were 15 individuals between the ages of 19 and 61, who were patients in the 
Tennessee Weight Loss & Surgery Center (University of Tennessee Medical Center, Knoxville). 
No post-operative patients were included in this study. 
Recruitment & Testing 
Participants were recruited following medical staff presentations on weight loss surgery 
and during support group meetings that prospective surgery patients were required to visit. 
Recruitment flyers were also left with medical staff of the Weight Loss and Surgery Center. A 
short presentation was given describing the objectives of the study. Afterwards, individuals were 
given the opportunity to ask additional questions. All participants signed an informed consent 
form. 
To be eligible for the study, participants had to be ≥18 years of age, diagnosed with class 
III obesity (BMI ≥40 kg·m-2 or BMI ≥35 kg·m-2 with medical comorbidities), and able to walk 
for six consecutive minutes without the use of an assistive device. Consent was received from the 
attending surgeon prior to beginning any testing. Individuals were deemed ineligible if they did 
not meet these criteria or if the physician knew of any other reasons contraindicating 
participation in the current study. The University of Tennessee Institutional Review Board and 
the University of Tennessee Graduate School of Medicine approved the protocol. 
Testing was completed at the University of Tennessee Medical Center. To reduce subject 
burden, testing was scheduled during regularly scheduled hospital visits whenever possible. 
Inside the Weight Loss & Surgery Center, age, sex, height, weight, hip circumference (HC), and 
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waist circumference (WC) were recorded. Walking bouts were completed in a hallway outside 
the Weight Loss & Surgery Center. 
Objective Physical Activity Monitors 
Participants wore shorts/pants with pockets and appropriate footwear for walking-based 
activities. Objective monitors were placed on various body locations in accordance with their 
respective manufacturers’ instructions. The Fitbit was worn on the right side of the waist. The 
SenseWear Pro 2 armband (SWA) (Software Version 7.0) was worn on the right tricep at the 
midpoint between the acromion and olecranon processes. The Omron HJ-720ITC pedometer 
(Omron Corporation, Kyoto, Japan) was worn in the pants pocket, while the Yamax SW-200 
Digiwalker (DW) (Yamasa Corporation, Tokyo, Japan) was clipped to the left side of the 
waistband. The StepWatch 3 (SW3) (software version 6.0) was worn on the right ankle, just 
above the lateral malleolus.  
As a criterion measure, steps were recorded via a hand tally counter by the principal 
investigator. Simultaneously, EE was measured by indirect calorimetry using the Oxycon Mobile 
portable metabolic system (Carefusion, San Diego, CA).  This device was worn on a harness, 
with the facemask covering the nose and mouth. The Oxycon O2 and CO2 analyzers were 
calibrated using a reference gas tank (16.0% O2 and 4.0% CO2) and room air, and the ventilation 
flow meter was calibrated with a 3-L syringe. 
Walking Bouts 
Participants were instructed to walk in a flat hallway at a self-selected pace for six 
consecutive minutes. Investigators instructed participants to select a pace that would allow them 




 All statistical analyses were performed using SPSS version 19 for Windows (SPSS, Inc., 
Chicago, IL). Descriptive measures of interest were height, weight, BMI, WC, HC, waist-to-hip 
ratio, walking speed, and walking EE. Percent errors for step counts and energy expenditure 
estimates were used to evaluate monitor accuracy. For comparison purposes, a value of 0% error 
was assigned to the criterion measures. Repeated measures analysis of variance (ANOVA) was 
used to determine if monitors differed in percent error for step counts. Pairwise comparisons 
were used to determine between-monitor differences in step-counting percent error. A paired 
samples t-test was used to determine if monitors differed in estimating Calories. To determine 
the metabolic cost of walking during steady state oxygen consumption, the final 3 minutes of 
indirect calorimetry values during each walking bout were averaged. To calculate percent errors, 
the following equation was used:  
% Error = [(Criterion value – Monitor value) / (Criterion value)] * 100% 
One sample t-tests were used to examine accuracy. Pearson’s correlations were used to explore 
the relationship between height, weight, BMI, walking speed, WC, HC, and WHR and device 
accuracy for step counts and Caloric expenditure. All p values were 2-tailed and were deemed 
statistically significant if p≤0.05.  
RESULTS 
 Physical characteristics of the participants are depicted in Table 1. All but one individual 
had a BMI ≥ 40 kg·m-2, and 14 of the 15 participants were female. Indirect calorimetry 
measurements were not obtained on one individual who was tested after a 12-hour fast in an 




 Figure 2 shows the results for step-counting percent errors. Repeated measures ANOVA 
found PE differed between devices [F(4,11)=4.447, p=0.022)]. Post-hoc comparisons showed 
that step-counting percent errors did not differ among the SW3, Omron, or Fitbit. The DW 
significantly differed from SW3 (p=0.035), Omron (p=0.008) and Fitbit (p=0.036) but not SWA 
(p=0.241). Step-counting percent error of the SWA was significantly greater than Omron 
(p=0.020) and marginally greater than Fitbit (p=0.068) and SW3 (p=0.078). One sample t-tests 
showed that the DW significantly under-counted steps by approximately 28% [t(14)=2.310, 
p=0.037)]. The SWA appeared to under-count steps by 12% [t(14)=1.844, p=0.086]. 
Energy Expenditure 
The SWA and Fitbit provided data on EE. A paired samples t-test found a significant 
difference between monitors [t(13)=-4.053, p=0.001)]. A one sample t-test found that during a 6-
minute walk SWA significantly overestimated Caloric expenditure by 71.6 ± 46.7% (p=0.003), 
while the Fitbit slightly overestimated EE by 10.02 ± 22.1% (p=0.114).  
Table 1. Participant Characteristics 
 Physical characteristic Mean (Standard Deviation) Range 
Age (years) 40.1 (12.5) 19-61 
Weight (kg) 131.9 (22.2) 90.5-169.6 
BMI (kg·m-2) 47.0 (5.9) 37-58.7 
WC (cm) 134.2 (23.2) 99.1-182.9 
HC (cm) 145.1 (15.3) 106.7-172.7 
WHR 0.92 (0.09) 0.78-1.10 
Walking EE (ml·kg-1·min-1) 9.24 (2.15) 5.33-12.93 
Walking Distance (m) 388.5 (105) 143.6-535.5 
Walking Speed (km·h-1) 3.89 (1.05) 1.43-5.36 
N=14 for walking EE. 
 
 
Figure 1. Percent errors in step counting during self
obesity. To evaluate device accuracy in relation to the hand tally criterion, mean percent 




Table 2. Actual steps recorded by hand tally counter and devices.
mean steps (standard deviation).
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Figure 2. Percent errors in total 
To evaluate device accuracy in relation to the indirect calorimetry criterion, mean percent 
errors were compared. All negative values reflect overestimates, and all positive values 
reflect underestimates. 
 
Table 3. Actual Calories recorded by indirect calorimetry, SWA, and Fitbit.
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The prevalence of class III obesity has increased over the past 20 years. Thus, accurate 
assessment of this group’s PA behaviors is of utmost importance. In a study involving 86 gastric 
bypass patients, leisure-time walking was the most commonly reported form of PA both before 
and after surgery [189]. The effectiveness of step-based programs relies heavily on the accuracy 
of the step-counting device.  
Of the five monitors tested in the current study, only DW step-count percent error 
differed significantly from zero. The SW3 produced the smallest margin of error, and no 
significant differences were observed among the SW3, Omron, and Fitbit. The SWA 
significantly overestimated the metabolic cost of walking, suggesting that the Fitbit may be a 
better tool for estimating walking EE in the bariatric population. In the present study, we 
observed that the spring-levered, waist-mounted DW undercounted steps by 28%. Past reports 
have also shown that the DW significantly undercounts steps in individuals with an elevated 
BMI [11, 14]. 
The placement of the SW3 on the ankle is likely responsible for its high degree of 
accuracy. In comparison to waist-mounted devices, ankle-mounted devices are less prone to error 
resulting from abdominal adiposity [190]. Slower walking speeds may not produce vertical 
accelerations at the hip capable of recording a step; the SW3 overcomes this obstacle by virtue of 
its placement on the ankle and also by responding to horizontal accelerations [15].  
During the 6-minute bout, the SWA greatly overestimated the metabolic cost of walking. 
When obese individuals completed a 5-minute treadmill walk, SWA estimates of EE were 
significantly greater than measured values from indirect calorimetry [186]. The reason the SWA 
overestimates EE cannot be determined, but the SWA also overestimates the metabolic cost of 
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walking in normal weight individuals, although to a lesser extent [185]. It should be noted, 
however, that the SWA is capable of accurately assessing 24-hour energy expenditure in healthy 
adults when compared with doubly labeled water [191]. The Fitbit only slightly overestimated 
EE during the walking bouts, and appears to be a better evaluative instrument for estimating 
Caloric expenditure during walking in patients who are severely obese. Interventionists should 
consider monitor accuracy when setting PA goals based on Caloric expenditure.  
 Previous studies have used predetermined walking speeds to assess step-counting 
accuracy [11, 13, 14]. We chose to attempt to evaluate the monitors at each participant’s self-
selected walking speed, because obese individuals are likely to walk slower than their normal 
weight peers [192]. Our participants walked an average of 388.5 m in 6 minutes, or 3.89 km·h-1. 
The average metabolic cost of walking of these individuals was 9.24 ± 2.15 ml·kg-1·min-1. These 
values are fairly similar to those of 57 obese women (BMI 37.1 ± 3.4 kg·m-2) reported by 
Mattson et al. [162]. In that study, the metabolic cost of walking was 11.1 ± 1.4 ml·kg-1·min-1 at 
an average self-selected speed of 4.25 km·h-1. In comparison, normal weight women prefer 
walking speeds of about 5.3 km·h-1 [193].  
The 6-minute walk test (6MWT) is a clinical test commonly used to evaluate functional 
capacities of persons with low exercise capacity [194]. The 6MWT requires the participant to 
walk as far as possible during the 6-minute period, and walking speed may decrease during the 
latter minutes of the test [195]. Average 6MWT distances for persons awaiting bariatric surgery 
have ranged from 393 m to 475.7 m [156, 158, 196]. In contrast, our participants were asked to 
walk at a self-selected pace that could be maintained for the entirety of the bout. Similar to the 
current study’s methods, de Souza et al. [197] instructed individuals awaiting bariatric surgery to 
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complete the 6MWT at their regular pace. In that study, the average pre-operative distance 
covered was 381.9 m (3.82 km·h-1). 
In addition to providing researchers with more accurate data, these devices can also be 
used by patients to self-monitor their PA levels during interventions. In a recent review, Bravata 
et al. [174] found the use of a pedometer, daily step goal, and PA log led to accumulation of an 
additional 2,500 steps·d-1.  Severely obese individuals given social support, a pedometer, and a 
walking diary increased daily steps by 47% over 18 weeks [198]. Though consistent self-
monitoring of exercise participation has been associated with greater weight loss [199], Burke et 
al. [200] note the need for validating and strengthening self-monitoring techniques. Furthermore, 
a number of patients remain severely obese following bariatric surgery [90-92], meaning that 
both pre- and post-operative PA must be assessed using devices validated for use in the severely 
obese. Use of objective monitors has the potential to limit subject burden that often accompanies 
PA diaries. While time constraints may prevent an individual from immediately logging 
activities, many monitors are capable of recording real-time data and storing it for several weeks. 
This feature could potentially allow medical staff to reduce the frequency of post-operative 
appointments used to assess patient adherence to exercise prescriptions. Some monitors also 
display step counts and Calories, eliminating the need for uploading data in order to receive 
feedback. 
CONCLUSION 
Results of the current study suggest that the SW3, Omron, and Fitbit are all capable of 
accurately measuring step counts in individuals with class III obesity, but the DW is not. A new 
finding was that the Fitbit was far more accurate than the SWA for estimating Caloric 
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expenditure. In conclusion, researchers aiming to assess PA in persons with class III obesity 
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